We're working on profiling this company soon. Let us know you're interested by sending us a request here »
We're working hard to bring you this company's profile. Register here to get an alert as soon we're done.
In the meantime, if you are interested in participating in placements on this stock click "Follow" on the toolbar above.
If you have a high tolerance for risk, then it could be worth checking out the small cap ASX share i...
Read ArticleASX falls 81 points or 0.92pc by end of trade Utilities and energy sectors the only resistance Fina...
Read ArticlePre-hospital mobile stroke unit ambulance study launched in Melbourne Study will assess First Respo...
Read ArticleFDA classifies medical devices based on the type of device and the level of risk it poses Three mai...
Read ArticleEMVision banks $12m to speed up stroke care devices Its portable scanners target the gap CT can’t f...
Read ArticleASX heath sector falls 1.09% over past five days, while broader markets down 0.66% for same period...
Read ArticleEmvision secures $12 million in a placement, with up to $3 million to come in a share purchase plan...
Read ArticleASX recovers from 0.7pc plunge to lose just 0.13pc Gains in energy offset larger losses in gold and...
Read ArticleWith more than seven million users on the HotCopper forums, every discussion and speculation can mov...
Read ArticlePerversely, Polynovo stands to benefit from a US reimbursement cut for outpatients ASX biotechs had...
Read ArticleASX slides 0.41pc as full year results disappoint Gold, Small Ords, Tech index enjoy late interest-...
Read ArticleLeading US stroke centre UCLA Health scheduled for site activation in EMVision’s pivotal trial of e...
Read ArticlePremier US stroke research hub UCLA Health will act as the site for a validation trial and continuou...
Read ArticleFraser Palamara chats with EMVision Medical Devices (ASX:EMV) CEO and managing director Scott Kirkla...
Read ArticleIn the medical device sector, sometimes trial news can excite investors more than the approval en...
Read ArticleASX closes out week-long rally on new record high of 8938 points Market set a new intraday high eve...
Read ArticleEye drug developer Opthea’s cash balance has more than halved as the company wraps up its failed tr...
Read ArticleEMVision receives ethics approval for two studies that will advance prototype First Responder towar...
Read ArticleEchoSolv enters Mayo’s gauntlet for FDA nod Echo’s AI flags heart failure before it hits the fan Ot...
Read ArticleASX health up 1.6% over five days as Morgans’ Scott Power says the mood is positive for start of FY...
Read ArticleAs today’s Medadvisor deal attests, underperforming biotech assets are getting a bite or two Next S...
Read ArticleFive of the six pivotal trial sites for EMVision’s emu device for stroke diagnosis now actively enr...
Read ArticleASX heath sector falls 1.1% over past five days The US FDA approves CSL’s Andembry to prevent attac...
Read ArticleHighlights: ASX health sector eased, diverging from the broader ASX 200 gains during the week...
Read ArticleASX health stocks dipped 0.82% over the past five days while the broader market has risen 1.26% EMV...
Read ArticleHighlights ASX 200 ended marginally lower as miners posted gains but healthcare and finance se...
Read ArticleDespite a strong start, the ASX has paired back gains to finish down 2.9 points or 0.03pc Weakness...
Read ArticleRamsay Health Care Australia CEO Carmel Monaghan joins board of EMVision Medical Devices Monaghan h...
Read ArticleHighlights ASX 200 marked a new short-term high, driven by gains in gold and banking sectors...
Read ArticleASX adds 52 points, hitting a new 50-day high at 8,466.70 points Broad strength with 9 of 11 sector...
Read ArticleStockhead’s Tylah Tully looks at the latest from EMvision Medical Devices (ASX:EMV), who have increa...
Read ArticleAI is reshaping microbiology in the labs Big Pharma taps Clever Culture’s APAS system Here are ASX...
Read ArticleASX health stocks up 0.57% over past week, while the broader market is up 0.35% Wave of capital ra...
Read ArticleNanosonics scores FDA De Novo approval in March EMVision is also targeting De Novo for its brain sc...
Read ArticleHighlights Energy, healthcare and telecommunications sectors drove market advances following a...
Read ArticleThe ASX 200 closed up 0.52% at 8,386 points. Energy was the best performing sector, up1%, followe...
Read ArticleEMVision Medical Devices advances its AI-driven stroke diagnostics Promising new data shows enhance...
Read ArticleEMVision (ASX:EMV), seeking to disrupt the brain scanner tech space, has sent off a second ‘Emu‘ bed...
Read ArticleASX heath sector falls 2.1%, while broader markets also fall 3.8% for the same period as US tariffs...
Read ArticleASX heath sector falls 2.1%, while broader markets rise 0.8% for the same period Opthea phase III C...
Read ArticleEMVision starts pivotal validation trial for emu bedside brain scanner to diagnose stroke The first...
Read ArticleA cabal of ASX drug developers has defied the US gloom The healthcare jury’s out on new FDA head Dr...
Read ArticleStockhead joins with IR Department and Morgans for HealthInvest 2025 in Sydney on April 2 Event to...
Read ArticleHighlights ASX 200 sees movement amid global trade shifts and domestic fiscal debates. Co...
Read ArticleWhat had been shaping into a solid little Week 13 for the ASX 200 has been pipped at the post headin...
Read ArticleHighlights ASX200 sees a slight upward trend with sector gains. Penny stocks offer unique gro...
Read ArticleThere are several ASX biotech companies developing drugs to treat complex neurological conditions G...
Read ArticleASX health stocks break losing streak, up 1.78% over past week, while the broader market rises 2.01...
Read ArticleTBI awareness month highlights need for better care ASX companies roll out devices to tackle TBI he...
Read ArticleEMVision Medical Devices (ASX: EMV) has completed aeromedical retrieval environment testing of its F...
Read ArticleStockhead’s Break it Down brings you today’s leading market news in under 90 seconds. In this episod...
Read ArticleEmvision to launch remote stroke detection trial It’s a tricky market but biotechs are raising fund...
Read ArticleEMVision is transitioning from R&D stage to commercialisation with its portable brain scanner...
Read ArticleEMVision is moving from R&D stage to commercialisation with its portable brain scanner to det...
Read ArticleHighlights Ceretas secures $1 million to further develop its breakthrough ultrasound therapy fo...
Read ArticleHighlights Australian penny stocks show growth potential amid market volatility EMVision (EMV),...
Read ArticleThe ASX200 has been up 0.25% at 8,505 points. Industrials has been the strongest performing secto...
Read ArticleIt’s starting to look like a flat Wednesday, with Aussie futures now pointing to a near-unnoticeable...
Read ArticleHaving lodged their paperwork, companies including EBR Systems, Artyra and Orthocell await crucial...
Read ArticleASX 200 drops as gold, iron ore and energy stocks struggle Paladin shares plunge after cutting uran...
Read ArticleEmvision expects to release trial results for its Emu stroke-detection device in November Syntara’s...
Read ArticleIn this interview Dale Gillham and small cap company director Rod North discuss what to look for in...
Read ArticleNyrada to launch phase I first-in-human trial after passing preclinical safety studies Neuren Pharm...
Read ArticleCurvebeam’s innovative products are revolutionising cone beam CT imaging The company’s HiRise offer...
Read ArticleFounder-led medical technology company EMVision (ASX: EMV) has today unveiled its proof of concept d...
Read ArticleASX in broad rebound; Cettire, Neuren, and Lendlease lead surge Positive sentiment follows Wall Str...
Read ArticleStage 2 interim data from a pre-validation trial by EMVision Medical Devices (ASX: EMV) has confirme...
Read ArticleEMVision’s AI algorithm shows promise EMvision Medical Devices (ASX:EMV) has shared an update from i...
Read ArticleASX 200 set to rise Monday, following New York’s rally US traders optimistic after Michigan su...
Read ArticleAustralian company EMVision Medical Devices (ASX:EMV) has secured a strategic $15.28 million...
Read ArticleEMvision receives strategic investment from NYSE-listed firm Radiopharm doses first patient in Phas...
Read ArticleASX to open lower, tracking Wall Street Fed member sees rate cuts this year as inflation data lo...
Read ArticleSo much for a small rise on the market today. Instead, the ASX200 closed down about three quarters (...
Read ArticleThe ASX200 has been trading down more than .4 per of a per cent today. Information technology...
Read ArticleEMVision (ASX:EMV) reveals the name of its inaugural point-of-care brain scanner device, ’emu’, at t...
Read ArticleASX medical devices to make inroads with FDA after a good year for drug developers FDA is reviewing...
Read ArticleEMVision Medical Devices (ASX:EMV) assembles an advanced 28-antenna prototype for its second-generat...
Read ArticleRecce Pharma moves forward to stronger dose in Phase 1/2 trial EMV is bench testing its 2nd Gen ult...
Read ArticleParadigm Biopharma set to submit application to TGA EMVision uses artificial intelligence simulatio...
Read ArticleShares to rise for third day in a row Wall Street lifted after comments from Fed official Gold and...
Read ArticleMedical devices offer faster route to commercialisation than drugs How newly listed Curvebeam AI ai...
Read ArticleStroke has long been recognised as being among Australia’s most costly disease groups. It occurs wh...
Read ArticleEMVision Medical Devices (EMV) reports all three of its clinical trial sites are now enrolling Th...
Read ArticleEMVision Medical Devices (ASX:EMV), which is developing portable brain imaging for stroke, h...
Read ArticleShares to open flat after the Fed bumped rates another 25bp Google, Microsoft and Meta reported ear...
Read ArticleEMVision Medical Devices (ASX:EMV) has received a cash progress payment of $1,750,000 under...
Read ArticleEMVision (ASX: EMV) founder Scott Kirkland will step into the CEO role from 1 July, succeeding Dr Ro...
Read ArticleEMVision Medical Devices (EMV) activates stage two of the multi-site trial for its first-generation...
Read ArticleThe ASX is set to rise on Monday on a relief rally Another chipmaker, Marvell, surges 32pc Shaq O’N...
Read ArticleEMVision Medical Devices (EMV) completes the enrolment of 30 healthy volunteers into its stage one c...
Read ArticleEMVision Medical Devices (EMV) completes enrolment of around half the 30 participants required for i...
Read ArticleEMVision Medical Devices (EMV) begins the multi-centre clinical trial of its brain scanner deviceFol...
Read ArticleLittle Green Pharma gets ethics approval to commence Phase 3 trial EMVision has commenced a clinica...
Read ArticleThe ASX will open lower on Wednesday, tracking Wall Street Apple has lost US$165 billion of market...
Read ArticleEMV Medical Devices delivered its first portable brain scanner Firebrick Pharma gets patent in Aust...
Read ArticleEMVision medical (EMV) delivers a portable brain scanner to the first clinical site in its multi-cen...
Read ArticleThe ASX is set to rally again on Monday Wall Street gained for two straight sessions since the infl...
Read ArticleShareCafeMarket surges to a five-month high after a shaky week: ASX up 2.68% at noon by Peter Milios...
Read ArticleShareCafeStocks of the Hour: EMV, VMS, TKM EMVision Medical Devices (ASX:EM...
Read Article11 Nov 2022 - A snapshot of the stocks on the move featuring EMVision (ASX:EMV), Venture Minerals (A...
Read ArticleEMVision Medical Devices (EMV) is set to pocket a $2.5 million grant from the New South Wales Medica...
Read ArticleEMVision Medical Devices (EMV) locks in $5 million in funding for the development and commercialisat...
Read ArticleASX to track Wall St higher on Tuesday Rishi Sunak poised to become next British PM Jim Chalmers wi...
Read ArticleEMVision (EMV) receives human research ethics committee (HREC) approval for its multi-centre Brain S...
Read ArticleThe ASX will open much higher on Tuesday Wall St came back from the ashes overnight, up by 2.5% RBA...
Read ArticleEarnings season is starting to slow down but thereâs still plenty of excitement for those interes...
Read ArticleLocal markets follow Wall St ‘hopetimism’ lower Small caps smashed, down circa 3% Pot stock CAU del...
Read ArticleHighlights The ASX 200 benchmark index closed lower today (29 August), losing 138.60 points or 1...
Read ArticleEMVision Medical Devices (EMV) will receive a grant under the Modern Manufacturing Initiative (MMI)...
Read ArticleHITIQ signs deal with English cricket EMVision gets $5m government grant ProMedicus signs new contr...
Read ArticleEMVision Medical Devices (EMV) confirms the first two clinical sites for upcoming trials of its bra...
Read ArticleEMVision Medical Devices (EMV) receives a $600,000 milestone payment from the Australian Stroke All...
Read ArticleEMVision Medical Devices (ASX: EMV) has received a $600,000 payment after achieving an “important mi...
Read ArticleASX is set to open sharply higher today after Friday’s big rally on Wall Street US major banks pass...
Read ArticleShareCafeWebinar Recap – EMV, KAL, TOR & TEM Catch up on the full webinar with presentations fr...
Read ArticleShareCafeEMVision (ASX: EMV) – Webinar Presentation Scott Kirkland – Executive Director & Dr Ro...
Read ArticleThe EMvision Medical Devices Ltd (ASX: EMV) share price rocketed today following news that the Aust...
Read ArticleShareCafeLunch Report: 18 May, 2022 by Melissa Darmawan Materials lift ASX higher for 4th day Aust...
Read ArticleEMVision Medical Devices (EMV) is awarded a grant under the Modern Manufacturing Initiative (MMI) p...
Read Article18 May 2022 - A snapshot of the stocks on the move featuring Eagers Automotive (ASX:APE), Boral (ASX...
Read ArticleAustralian medtech EMVision Medical Devices (ASX: EMV) has been awarded $5 million in non-dilutive c...
Read ArticleEmerging markets index ends flat ASX200 0.5 higher Chinese economy hit by COVID-lockdowns Anaemi...
Read ArticleEmerging markets index ends flat ASX200 0.5 higher Chinese economy hit by COVID-lockdowns Anaemi...
Read ArticleThe EMvision Medical Devices Ltd (ASX: EMV) share price has emerged from a trading halt on Wednesda...
Read ArticleMedTech company EMVision (ASX: EMV) has signed an exclusive 12-month agreement with Keysight Technol...
Read ArticleEMVision Medical Devices (EMV) partners with Keysight Technologies Australia to continue developing...
Read ArticleMedical imaging technology company EMVision Medical Devices (ASX: EMV) has revealed it has secured a...
Read ArticleEMVision Medical Devices (ASX: EMV) has announced its device development and multi-centre clinical t...
Read ArticleThe ASX 200 Health Index (XHJ) is up by 0.30% at the time of writing, compared to the broader index...
Read ArticleEmVision Medical Devices (EMV) has welcomed new members to its Clinical Advisory Board in an ex-off...
Read ArticleQueensland-based EMVision Medical Devices (ASX: EMV) has added three respected experts in the field...
Read ArticleMedical imaging company EMVision Medical Devices (EMV) has continued to progress development and co...
Read ArticleEMVision Medical Devices (ASX: EMV) has continued advancing development and commercialisation plans...
Read ArticleThe ASX 200 Health Index (XHJ) is down by 0.20% at the time of writing, compared to the broader inde...
Read ArticleEMVision Medical Devices (EMV) receives a total non-dilutive funding injection of $3.4 million Foll...
Read ArticleThe ASX returned to positive territory today as investors began to shrug off fears of the omicron va...
Read ArticleEMVision Medical Devices (EMV) spikes on the ASX after releasing further results from a pilot clini...
Read ArticleEMVision (ASX:EMV) is developing a portable brain scanner called the 1st Gen, a device for use in IC...
Read ArticleAfter a positive start the ASX finished down over 0.5%. Today, APRA ordered the big banks to increas...
Read ArticleThe EMvision Medical Devices Ltd (ASX: EMV) share price has spent the morning in the red. It is cur...
Read ArticleWall Street rebounds US stocks staged a rebound overnight, following Monday’s tech-driven selloff. A...
Read ArticleThe ASX 200 health stocks index (XHJ) has lifted by 0.46% at the time of writing, compared to the br...
Read ArticleThe EMvision Medical Devices Ltd (ASX: EMV) share price is charging higher today. This follows the...
Read ArticleSummary A panic selling in oil and gold prices and concerns over the rapid spread of the Delta v...
Read ArticleThe ASX200 health stocks index (XHJ) fell by 0.14% this morning, compared to the broader index which...
Read ArticleWall Street mixed as oil and metals fall US stock markets were mixed on Monday, as oil prices fell t...
Read ArticleThe ASX Healthcare index rose by 0.45% this morning, compared with the broader index which fell by 0...
Read ArticleWall Street, Oil plunge on rising COVID cases All three benchmark indices in the US tumbled on Monda...
Read ArticleThe diagnostics imaging industry has come a long way since the days of X-rays and CT scans – two tec...
Read ArticleQueensland-based EMVision Medical Devices (ASX: EMV) has reported significant advances to the design...
Read ArticleFor all the leaps and bounds in medical science, the know-how behind detecting diseases hasn’t chang...
Read ArticleEMVision Medical Devices Ltd (ASX: EMV) shares were on the rise today following news of two signifi...
Read ArticlePortable brain scanning technology developed by EMVision Medical Devices (ASX: EMV) has been further...
Read ArticleWith health issues at the global forefront over the past year, it’s no surprise that Australia’s hea...
Read ArticleThe EMVision Medical Devices Ltd (ASX:EMV) share price is up more than 13%. After moving up the cha...
Read ArticleThe EMvision Medical Devices Ltd (ASX: EMV) share price closed 13.2% higher today after the company...
Read ArticleMedical imaging technology company EMVision Medical Devices (ASX: EMV) is set to receive $8 million...
Read ArticleASX health stocks EMvision (ASX:EMV) and 4D Medical (ASX:4DX) have been awarded over $37 million bet...
Read ArticleEMvision Medical Devices Ltd (ASX: EMV) shares are unchanged today after the company announced a tr...
Read ArticleMedical imaging technology developer EMVision Medical Devices (ASX: EMV) has elected to expand on an...
Read ArticlePeter Switzer talks to Dr Ron Weinberger, CEO and Managing Director of EMvision (EMV).
Read ArticleShareCafeHidden Gems Webinar Recap – NTI, RLG, 3DP, EMV Catch up on the full webinar with presentat...
Read ArticleShareCafeEMVision (ASX:EMV) – Hidden Gems Webinar Presentation Presenter – Scott Kirkland – Executi...
Read ArticleSummary The pandemic has changed the fundamentals of the way businesses work across the globe wh...
Read ArticleThe EMvision Medical Devices Ltd (ASX: EMV) share price has opened lower this morning despite the c...
Read ArticleQueensland-based EMVision Medical Devices (ASX: EMV) has reported encouraging data from a pilot clin...
Read ArticleASX companies continued to raise money in July, with over $4bn shelled out by investors, taking 2020...
Read ArticleNearly two years of pain for Factor Therapeutics (ASX:FTT) shareholders could be over soon with the...
Read ArticleListed imaging technology outfit EMvision Medical Devices was fronting funds on Wednesday morning, o...
Read ArticleEMvision Medical Devices (ASX:EMV) chief Ron Weinberger brings a rarefied perspective to the prospec...
Read ArticleThe COVID-19 pandemic has led to 527 clinical trials being shut down in Australia and New Zealand th...
Read ArticleEMVision Medical Devices (ASX: EMV) has released what it claims is “promising” first stroke patient...
Read ArticleNoxopharm (ASX:NOX) is the latest biotech to announce it will test its drug against COVID-19. So how...
Read ArticleFor an update on the company's progress in developing a portable brain scanner for detecting stroke,...
Read ArticleEMVision Medical Devices (EMV) has boosted its cash reserves over the last quarter ahead of clinica...
Read ArticleCann Group (ASX:CAN) is pulling back from its original ambitious Mildura cannabis growing warehouse,...
Read ArticleEMVision Medical Devices (EMV) has made significant progress in commencing clinical trials targetin...
Read ArticleMedical devices are considered as an essential part of the health care industry and range from a ban...
Read ArticleEMVision Medical Devices Limited (ASX: EMV) receives binding commitments from the institutional and...
Read ArticleIn what has been described as a medical breakthrough, listed med-tech EMVision (ASX: EMV) has unveil...
Read ArticleIn what has been described as a medical breakthrough, med-tech EMVision (ASX: EMV) has unveiled its...
Read ArticleQueensland’s EMVision Medical Devices (ASX: EMV) has announced a year-end target for clinical trials...
Read ArticleDid you know that on 16 September 2008 Lehman Brothers filed for Chapter 11 bankruptcy protection. T...
Read Article
Open an account with an online broker of your choice. If you do not have an existing broker, consider Vested Equities' A$9.50 flat fee platform.
Sign up now »Place your order however you wish. If you need advice on buying or selling, you should seek the assistance of a full service financial adviser experienced in small cap equities.
